People · Operator
Named in public records as an officer, director or promoter · active 2010–2022 · Biotechnology, Media & Content
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Sangart Inc | — | Biotechnology | Series D+ | $165.9M | $4.2B | 2010 |
| Adaptive Studios, Inc | — | Media & Content | Series B | $27.5M | $265.8M | 2017 |
| I2Pure Corp. | — | Biotechnology | Pre-Seed | $300K | $3.7M | 2022 |
Joseph Steinberg at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Joseph Steinberg on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Gallagher | 1 | 6 |
| Thomas Davis | 1 | 3 |
| John Eyring | 1 | 1 |
| Ian Cumming | 1 | 1 |
| BRIAN O'CALLAGHAN | 1 | 1 |
| DAVID RENAS | 1 | 1 |
| TJ Barrack | 1 | 1 |
| Marc Joubert | 1 | 1 |
| Perrin Chiles | 1 | 1 |
| Douglas Spitz | 1 | 1 |
| Rob Painter | 1 | 1 |
| Jack Kessler | 1 | 1 |
| Lee Larson | 1 | 1 |
| Joshua Reader | 1 | 1 |
| Grady Gamble | 1 | 1 |
| Jonathan Grunzweig | 1 | 1 |
| JUSTIN WHEELER | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.